These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33335905)

  • 21. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
    Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
    Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].
    Lu X; Han Y; Gao X; Wang F; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1056-1060. PubMed ID: 33081890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a Lower vs Higher Positive End-Expiratory Pressure Strategy on Ventilator-Free Days in ICU Patients Without ARDS: A Randomized Clinical Trial.
    ; Algera AG; Pisani L; Serpa Neto A; den Boer SS; Bosch FFH; Bruin K; Klooster PM; Van der Meer NJM; Nowitzky RO; Purmer IM; Slabbekoorn M; Spronk PE; van Vliet J; Weenink JJ; Gama de Abreu M; Pelosi P; Schultz MJ; Paulus F
    JAMA; 2020 Dec; 324(24):2509-2520. PubMed ID: 33295981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.
    Kor DJ; Carter RE; Park PK; Festic E; Banner-Goodspeed VM; Hinds R; Talmor D; Gajic O; Ware LB; Gong MN;
    JAMA; 2016 Jun; 315(22):2406-14. PubMed ID: 27179988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of statins in ARDS: the quest for the Holy Grail continues.
    Grimaldi D; Durand A; Gleeson J; Taccone FS
    Minerva Anestesiol; 2016 Nov; 82(11):1230-1234. PubMed ID: 27232279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
    Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
    Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors of the occurence and death of acute respiratory distress syndrome: a prospective multicenter cohort study].
    Ge Q; Yao Z; Wang T; Liu Z; Li A; Wang S; Li G; Bian W; Chen W; Yi L; Yang Z; Tao L; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):773-9. PubMed ID: 25399889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; Adourian A; Böhm M; van Veldhuisen DJ; Komajda M; Cleland JG; Wikstrand J; McMurray JJ; Aukrust P;
    Eur Heart J; 2012 Sep; 33(18):2290-6. PubMed ID: 22513778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of the dynamic changes in extra vascular lung water index and angiopoietin-2 in severe multiple trauma patients with acute respiratory distress syndrome].
    Dong Y; Liang X; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):571-576. PubMed ID: 31198142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of neutrophils to lymphocytes and platelets ratio for 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study.
    Nie S; Wang H; Liu Q; Tang Z; Tao W; Wang N
    BMC Pulm Med; 2022 Aug; 22(1):314. PubMed ID: 35971101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of risk factors of acute respiratory distress syndrome secondary to severe multiple trauma].
    Qin Y; Wang P; Xu X; Li Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):299-304. PubMed ID: 33834970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.
    Ridker PM; MacFadyen J; Cressman M; Glynn RJ
    J Am Coll Cardiol; 2010 Mar; 55(12):1266-1273. PubMed ID: 20206456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying novel clinical phenotypes of acute respiratory distress syndrome using trajectories of daily fluid balance: a secondary analysis of randomized controlled trials.
    Wu F; Shi S; Wang Z; Wang Y; Xia L; Feng Q; Hang X; Zhu M; Zhuang J
    Eur J Med Res; 2024 May; 29(1):299. PubMed ID: 38807163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
    Fellström BC; Jardine AG; Schmieder RE; Holdaas H; Bannister K; Beutler J; Chae DW; Chevaile A; Cobbe SM; Grönhagen-Riska C; De Lima JJ; Lins R; Mayer G; McMahon AW; Parving HH; Remuzzi G; Samuelsson O; Sonkodi S; Sci D; Süleymanlar G; Tsakiris D; Tesar V; Todorov V; Wiecek A; Wüthrich RP; Gottlow M; Johnsson E; Zannad F;
    N Engl J Med; 2009 Apr; 360(14):1395-407. PubMed ID: 19332456
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.